Kits Eyecare Ltd.
KTYCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.36 | 1.62 | 0.26 | -0.05 |
| FCF Yield | 3.70% | 0.97% | 5.57% | -25.28% |
| EV / EBITDA | 31.37 | 102.11 | -42.19 | -6.26 |
| Quality | ||||
| ROIC | 5.39% | -1.64% | -4.61% | -17.01% |
| Gross Margin | 33.67% | 33.85% | 31.92% | 25.35% |
| Cash Conversion Ratio | 4.18 | -1.09 | -1.03 | 1.33 |
| Growth | ||||
| Revenue 3-Year CAGR | 20.25% | 13.51% | 6.80% | 30.71% |
| Free Cash Flow Growth | 436.54% | -58.32% | 119.13% | -683.62% |
| Safety | ||||
| Net Debt / EBITDA | -0.80 | -0.35 | -0.34 | -0.16 |
| Interest Coverage | 4.53 | -0.92 | -2.67 | -11.44 |
| Efficiency | ||||
| Inventory Turnover | 4.70 | 5.17 | 3.80 | 4.56 |
| Cash Conversion Cycle | 8.06 | 16.99 | 14.79 | 32.34 |